Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Shook

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
NIDA Research Monograph|January 1, 1987
A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent miceJ E Shook, J T Pelton, W Kazmierski, et al.
Circulatory Shock|November 1, 1989
Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboonsE M Camporesi, S Oda, P J Fracica, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivoT H Kramer, J E Shook, W Kazmierski, et al.
Annals of Emergency Medicine|January 29, 1999
A prospective, population-based study of the demographics, epidemiology, management, and outcome of out-of-hospital pediatric cardiopulmonary arrestP E Sirbaugh, P E Pepe, J E Shook, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1990
Cerebral oxygen availability by NIR spectroscopy during transient hypoxia in humansN B Hampson, E M Camporesi, B W Stolp, et al.
Journal of Medicinal Chemistry|November 1, 1988
Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptorsW Kazmierski, W S Wire, G K Lui, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitroP K Lemcke, E Sugg, M Malarchik, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
NIDA Research Monograph|January 1, 1987
A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent miceJ E Shook, J T Pelton, W Kazmierski, et al.
Circulatory Shock|November 1, 1989
Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboonsE M Camporesi, S Oda, P J Fracica, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivoT H Kramer, J E Shook, W Kazmierski, et al.
Annals of Emergency Medicine|January 29, 1999
A prospective, population-based study of the demographics, epidemiology, management, and outcome of out-of-hospital pediatric cardiopulmonary arrestP E Sirbaugh, P E Pepe, J E Shook, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1990
Cerebral oxygen availability by NIR spectroscopy during transient hypoxia in humansN B Hampson, E M Camporesi, B W Stolp, et al.
Journal of Medicinal Chemistry|November 1, 1988
Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptorsW Kazmierski, W S Wire, G K Lui, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitroP K Lemcke, E Sugg, M Malarchik, et al.
Pageof 5